NCT06443268Recrutement en cours
Cerebrovascular Disease: Quality of Life (CODE: QoL)
Résumé
The goal of this observational study is to learn about quality of life, stress and caregiver burden in patients with stroke and their caregivers. The main question is: • to discover the factors associated with quality of life and stress in patient-caregiver dyads. Participants will be asked to fill out questionnaires and agree to provide a hair sample (in order to measure stress hormones in hair) and consent to use of their routine clinical and laboratory data. Researchers will compare a group of participants without stroke to establish a comparable baseline.
Critères d'éligibilité
Control group: Inclusion criteria: • over 18 years old • No previous stroke OR previous stroke \>3 years ago • No significant disability (maximum mRS 1) • ambulatory patients at the University Hospital of Zurich (USZ), Dept. of Neurology • Patients' AND caregiver's ability to give informed consent • Patients' AND close relative's / caregiver's willingness to participate Exclusion criteria: • Medication with steroid hormones (prednisone, prednisolone, dexamethasone, methylprednisolone, hydrocortisone etc.) within last 3 months Main Group: Inclusion criteria: • over 18 years old • Patients diagnosed with either transient ischemic attack, ischemic stroke or intracerebral hemorrhage and their caregivers • Caregiver of a patient as described above, age over 18 years • Hospitalized or ambulatory patients at the University Hospital of Zurich (USZ) included within 28 days from event. • Patients' AND caregiver's ability to give informed consent • Patients' AND caregiver's willingness to participate Exclusion criteria: • Medication with steroid hormones (prednisone, prednisolone, dexamethasone, methylprednisolone, hydrocortisone etc.) within last 3 months
Contacts
Les coordonnées de l'équipe de l'essai s'affichent sur demande.
Voir la fiche officielle de l'essai- Statut
- Recrutement en cours
- Phase
- —
- Type d'étude
- Observationnelle
- Pays
- Suisse
- Promoteur
- University of Zurich(Autre)
- N° de protocole
- 2023-00224
- Pathologies
- Quality of Life, Stroke, Acute, Sexual Behavior, Stress, Cortisol Excess, Incontinence, Urinary, Caregiver Burden, Transient Ischemic Attack, Intracerebral Hemorrhage, Cerebrovascular Disorders
- Interventions
- Test diagnostique
Traitements évalués
- questionnaire, hair samples, blood samples, clinical exam
Lieux · 1
- Zurich, SuisseDepartment of Neurology, University Hospital ZurichRecrute dans ce centre
Au total, dans le monde, le seul centre listé au registre recrute.
Statut par centre selon le registre ClinicalTrials.gov (dernière mise à jour publiée : 5 juin 2024).
Ce statut peut avoir changé et ne dit rien de votre éligibilité : avant toute démarche, vérifiez avec votre oncologue ou le centre.
Autres identifiants
- 2023 · financement NIH
Voir aussi
Autres versions
Ces résultats sont indicatifs et ne remplacent pas un avis médical — à discuter avec votre médecin.